Annual CFI
-$1.10 M
+$6.41 M+85.36%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual cash flow from investing activities is -$1.10 million, with the most recent change of +$6.41 million (+85.36%) on December 31, 2023.
- During the last 3 years, ACHL annual CFI has risen by +$10.75 million (+90.71%).
- ACHL annual CFI is now -16.77% below its all-time high of -$942.00 thousand, reached on December 31, 2019.
Performance
ACHL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
N/A
September 1, 2024
Summary
- ACHL quarterly cash flow from investing activities is not available.
Performance
ACHL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
September 1, 2024
Summary
- ACHL TTM cash flow from investing activities is not available.
Performance
ACHL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ACHL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.4% | - | - |
| 3 y3 years | +90.7% | - | - |
| 5 y5 years | -16.8% | - | - |
ACHL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.6% | ||||
| 5 y | 5-year | -16.8% | +90.7% | ||||
| alltime | all time | -16.8% | +90.7% |
Achilles Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$695.00 K(+53.1%) | -$695.00 K(-88.6%) |
| Dec 2023 | -$1.10 M(-85.4%) | - | - |
| Mar 2023 | - | -$454.00 K(-77.5%) | -$6.10 M(-18.7%) |
| Dec 2022 | -$7.51 M(-1.6%) | -$2.02 M(+6.1%) | -$7.51 M(+0.2%) |
| Sep 2022 | - | -$1.90 M(+9.4%) | -$7.50 M(+10.0%) |
| Jun 2022 | - | -$1.74 M(-6.8%) | -$6.82 M(-4.2%) |
| Mar 2022 | - | -$1.86 M(-7.0%) | -$7.12 M(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$7.63 M(-35.6%) | -$2.00 M(+64.2%) | -$7.63 M(+35.5%) |
| Sep 2021 | - | -$1.22 M(-40.2%) | -$5.63 M(+27.6%) |
| Jun 2021 | - | -$2.04 M(-14.3%) | -$4.41 M(+85.7%) |
| Mar 2021 | - | -$2.38 M(+283.8%) | -$2.38 M(+283.8%) |
| Dec 2020 | -$11.85 M(+1157.6%) | - | - |
| Mar 2020 | - | -$619.00 K | -$619.00 K |
| Dec 2019 | -$942.00 K | - | - |
FAQ
- What is Achilles Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Achilles Therapeutics?
- What is Achilles Therapeutics annual CFI year-on-year change?
- What is the all time high quarterly CFI for Achilles Therapeutics?
- What is the all time high TTM CFI for Achilles Therapeutics?
What is Achilles Therapeutics annual cash flow from investing activities?
The current annual CFI of ACHL is -$1.10 M
What is the all time high annual CFI for Achilles Therapeutics?
Achilles Therapeutics all-time high annual cash flow from investing activities is -$942.00 K
What is Achilles Therapeutics annual CFI year-on-year change?
Over the past year, ACHL annual cash flow from investing activities has changed by +$6.41 M (+85.36%)
What is the all time high quarterly CFI for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly cash flow from investing activities is -$454.00 K
What is the all time high TTM CFI for Achilles Therapeutics?
Achilles Therapeutics all-time high TTM cash flow from investing activities is -$619.00 K